Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells-Reference-Cited by-同舟云学术

Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells

Published:2017-10-26 Issue:6 Volume:121 Page:971-978
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Porter Laura H.¹²,Hashimoto Kohei¹³,Lawrence Mitchell G.¹²,Pezaro Carmel¹⁴,Clouston David⁵,Wang Hong¹,Papargiris Melissa¹⁶,Thorne Heather⁷⁸,Li Jason⁹,Ryan Andrew⁵,Norden Sam⁵,Moon Daniel¹⁰¹¹^ORCID,Bolton Damien M.¹²¹³^ORCID,Sengupta Shomik¹²¹³^ORCID,Frydenberg Mark¹¹⁴,Murphy Declan G.⁸¹⁵^ORCID,Risbridger Gail P.¹²,Taylor Renea A.¹¹⁶^ORCID,

Affiliation:

1. Department of Anatomy and Developmental Biology; Biomedicine Discovery Institute; Cancer Program; Monash University; Melbourne Vic. Australia

2. Prostate Cancer Research Program; Cancer Research Division; Peter MacCallum Cancer Centre; University of Melbourne; Melbourne Vic. Australia

3. Department of Urology; Sapporo Medical University School of Medicine; Sapporo Hokkaido Japan

4. Eastern Health Clinical School; Monash University; Melbourne Vic. Australia

5. TissuPath; Mount Waverley Vic. Australia

6. Australian Prostate Cancer Bioresource; Victorian Node; Monash University; Melbourne Vic. Australia

7. kConFab, Research Department; Peter MacCallum Cancer Centre; Melbourne Vic. Australia

8. Sir Peter MacCallum Department of Oncology; University of Melbourne; Melbourne Vic. Australia

9. Bioinformatics Core; Peter MacCallum Cancer Centre; University of Melbourne; Melbourne Vic. Australia

10. Epworth Healthcare; Richmond Vic. Australia

11. Central Clinical School; Monash University; Melbourne Vic. Australia

12. Department of Urology; Austin Hospital, Melbourne; Heidelberg Vic. Australia

13. Department of Surgery; University of Melbourne; Melbourne Vic. Australia

14. Department of Surgery; Monash University; Melbourne Vic. Australia

15. Division of Cancer Surgery; Peter MacCallum Cancer Centre; University of Melbourne; Melbourne Vic. Australia

16. Department of Physiology; Biomedicine Discovery Institute; Cancer Program; Monash University; Melbourne Vic. Australia

Funder

National Health and Medical Research Council

Victorian Cancer Agency

EJ Whitten Foundation

Peter and Lyndy White Foundation

TissuPath Pathology

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14043/fullpdf

Reference31 articles.

1. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance;Guo;Mod Pathol,2006

2. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy;Kwast;Eur J Cancer,2012

3. The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation;Kato;Mod Pathol,2016

4. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens;Kimura;Prostate,2014

5. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis;Risbridger;Eur Urol,2015

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The highs and lows of grading intraductal carcinoma of the prostate;Journal of Clinical Pathology;2024-06-14

2. Co‐targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer;The Journal of Pathology;2024-04-05

3. Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate;Journal of Cancer Research and Clinical Oncology;2024-01-28

4. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review;Cancers;2024-01-25

5. Molecular complexity of intraductal carcinoma of the prostate;Cancer Medicine;2024-01